# The Arrhythmogenic Potential of Midwall Septal Fibrosis in Dilated Cardiomyopathy

> **NCT05026112** · — · UNKNOWN · sponsor: **University College, London** · enrollment: 120 (estimated)

## Conditions studied

- Dilated Cardiomyopathy

## Interventions

- **DIAGNOSTIC_TEST:** ECG-Imaging
- **DIAGNOSTIC_TEST:** Cardiac MRI scan

## Key facts

- **NCT ID:** NCT05026112
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-01
- **Primary completion:** 2023-10-01
- **Final completion:** 2024-10-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2022-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05026112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05026112, "The Arrhythmogenic Potential of Midwall Septal Fibrosis in Dilated Cardiomyopathy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05026112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
